Economy

No curb on export of APIs, formulations from SEZ units: DGFT

PTI New Delhi | Updated on March 22, 2020 Published on March 22, 2020

Export restrictions imposed on certain APIs and formulations, including paracetamol, vitamin B1 and B12, are not applicable for units in special economic zones (SEZs), according to a commerce ministry circular.

On March 3, exports of 26 APIs and formulations, including paracetamol, vitamin B1 and B12, have been put under restricted category amid the coronavirus outbreak in China.

The Directorate General of Foreign Trade (DGFT), an arm of the ministry, said that it has received various representations from SEZ units and other exporters highlighting issues faced by them on account of the decision to put this export restriction.

“It is, therefore, clarified that the exports of restricted APIs and formulations made from these APIs are allowed from SEZ units,” the circular said.

Imposing restrictions means export of these active pharmaceutical ingredients (APIs) and formulations require a licence from the DGFT.

SEZs, developed as export hubs, are treated as a foreign territory in terms of customs laws. These units import raw material and export final products.

The pharmaceutical industry has urged the government to lift these restrictions on the export of active pharmaceutical ingredients and formulations.

Published on March 22, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.